Testing the safety of oral AFA-281 for alcohol use disorder
Part of Brain & nervous system, Mental health clinical trials.
This trial tests an experimental medication called AFA-281 to see if it's safe and could help reduce heavy drinking in people with moderate to severe alcohol use disorder. You must drink a high number of drinks per week to qualify.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 65 years old.
- You have been diagnosed with moderate or severe alcohol use disorder in the past year.
- You drink at least 28 drinks per week (if male) or 21 drinks per week (if female) over the last month.
- You are not currently being treated for alcohol use and haven't been in the last month.
- You do not have dependence on drugs other than alcohol or nicotine (except maybe caffeine).
- You are in good general health and do not have serious heart, liver, or other medical issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a mild nerve stimulation device (tAN) can help reduce alcohol cravings and withdrawal. It's for people with moderate to severe alcohol use disorder who are going through withdrawal and do not use tobacco.
This study tests whether a pill called apremilast can help reduce drinking in people with alcohol use disorder. You'll take the medication and attend regular visits to see how it affects your alcohol cravings and use.
This study tests how alcohol interacts with a new drug called AFA-281 in healthy adults. You may qualify if you regularly drink alcohol but do not have alcohol use disorder.
This study tests a new way to quickly screen medications for alcohol use disorder (AUD). You will have lab sessions where your drinking is monitored to see how different medicines affect your alcohol use.
This Phase 2 study tests a brief medication approach meant to reduce “problem drinking.” It may help people cut back or stop alcohol use by adjusting brain signaling related to drinking cravings and urges.
This early-phase study looks at how the brain’s opioid receptor balance may be different in people with alcohol use disorder (AUD), using brain scans and blood testing. It may help researchers understand why some people respond differently to alcohol and related treatments.
Hear when a new Alcohol Abuse trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.